Join Telegram
LIVE16 Oct 2026, 07:05 PM IST
← All Rights Issues
OPEN 100% data coverage

Natco Pharma Ltd. Rights Issue 2026

Natco Pharma is raising fresh equity through a rights issue offered to eligible shareholders in the ratio of 2 rights shares for every 21 shares held on the record date.

NATCOPHARM · BSE, NSE · Last checked 16 Oct 2026, 06:51 PM IST
Issue Price₹750.00 Rights ratio 2:21 ₹1,279.36 Cr issue size
Record Date01 Oct 2026
Entitlement2:21
Rights / 100 Shares9.52
Capital / 100 Shares₹7,142.86
Issue Closes22 Oct 2026
OFFER SNAPSHOT

Complete rights issue terms

100% verified fields
Record date01 Oct 2026
Entitlement ratio2:21
Issue price₹750.00
Face value₹2.00
Issue size₹1,279.36 Cr
Shares offered17,058,082
Issue opens12 Oct 2026
RE trading closes16 Oct 2026
Issue closes22 Oct 2026
AllotmentTBA
CreditTBA
ListingTBA
ENTITLEMENT VISUAL

Ownership impact

8.7%new shares
Existing shares91.3%
Rights shares8.7%
If you do not participate8.7% potential dilution
Existing base21.00
Post-rights base23.00
PAYMENT STRUCTURE

Cash requirement

On application₹750.00
Future call(s)None disclosed

₹750 per share payable as per the Letter of Offer.

OFFER TIMELINE

Important dates

4 / 7 dates available
01 Record date 01 Oct 2026
02 Issue opens 12 Oct 2026
03 RE closes 16 Oct 2026
04 Issue closes 22 Oct 2026
05 Allotment Awaited
06 Credit Awaited
07 Listing Awaited
DERIVED ANALYTICS

What the ratio means for you

For 100 shares held9.52 rights shares

Approximate entitlement before rounding rules in the Letter of Offer.

Subscription cash₹7,142.86

Approximate total issue-price consideration per 100 existing shares.

New equity weight8.7%

Rights shares as a share of post-issue equity if fully subscribed.

Existing equity weight91.3%

Share of post-issue equity represented by the pre-issue base.

Objects of the issue

Use of fundsFund requirements disclosed in the Letter of Offer, including balance-sheet and corporate purposes.
OFFER ANALYSIS

How to read this issue

Entitlement2:21

The number of rights shares offered relative to shares held on the record date.

Pricing₹750.00

Compare the rights price with the prevailing market price and adjust for dilution rather than looking at the discount alone.

PaymentFully paid / single call

₹750 per share payable as per the Letter of Offer.

LiquidityCheck RE trading

RE liquidity may be limited, especially in smaller companies. Review spreads, volumes and the last trading date before transacting.

Dilution8.7%

Approximate ownership dilution for a non-participating shareholder if the issue is fully subscribed.

Issue purposeDisclosed

Assess whether funds support growth, working capital or debt reduction, or are primarily covering ongoing financial stress.

RISK CHECK

Key points to verify

CheckCheck the market price versus the ₹750 issue price before acting.
CheckRights Entitlements must be subscribed or renounced before the applicable deadline; otherwise they lapse.
APPLICATION GUIDE

Before you subscribe

  1. Confirm your eligibility and RE quantity in demat.
  2. Read the Letter of Offer and payment schedule.
  3. Compare the issue price with market price and expected dilution.
  4. Review the object of the issue, leverage, profitability and cash-flow context.
  5. Check whether the issue is fully paid or has future calls.
  6. If renouncing, act before the RE trading/transfer deadline.
  7. If subscribing, complete ASBA/application before issue closure.
SOURCE & VERIFICATION

Data provenance

Hourly tracker refresh

IPO News prioritises exchange filings, issuer investor-relations documents and the Letter of Offer. Secondary rights-issue trackers are used for discovery and change detection. Final dates, ratios, payment calls and application procedures should be confirmed against the official offer documents.

Last tracker refresh16 Oct 2026, 06:51 PM IST
Data coverage100%
Primary sourceAvailable

Rights Issue FAQs

Do I automatically receive shares if I receive an RE?

No. An RE is an entitlement. You still need to apply and pay according to the issue terms.

Can I buy an RE if I was not a shareholder on the record date?

Generally yes, where RE trading is available. Buying the RE and applying for the rights shares are separate steps.

What happens if I do not use the RE?

Unused REs can lapse after the relevant deadline. They do not automatically become shares or cash.

How should I interpret a large entitlement ratio?

A larger ratio means more new shares relative to the existing share base. That increases both the capital required to maintain proportional ownership and the dilution for holders who do not participate.

Is a lower rights price always a bargain?

No. The economics depend on dilution, business fundamentals, use of proceeds, market price, payment calls and the overall terms of the issue.